Press release

Business Wire1 week ago

United Security Bancshares Declares Quarterly Cash Dividend

FRESNO, Calif.–(BUSINESS WIRE)–On December 16, 2025, the Board of Directors of United Security Bancshares (the “Company”) (NASDAQ: UBFO), the parent…
Read More »
Business Wire1 week ago

Morningstar and PitchBook Bring Trusted Investing Intelligence to Apps in ChatGPT

Morningstar and PitchBook’s Model Context Protocol (MCP) app integrations are now live, enabling licensed users to access proprietary public and…
Read More »
Business Wire1 week ago

Granite REIT Declares Distribution for December 2025

TORONTO–(BUSINESS WIRE)–Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has…
Read More »
Cision PR Newswire1 week ago
0

Clywedog Therapeutics Announces Activation of All Centers and Patient Dosing in Multicenter, International Phase 1b Clinical Study of Balomenib in Type 2 Diabetes

DOVER, Del., Dec. 17, 2025 /PRNewswire/ — Clywedog Therapeutics, Inc., a clinical-stage biotechnology company advancing novel therapies for metabolic diseases,…
Read More »
Cision PR Newswire1 week ago
0

Brasswater Acquires Mont Tremblant Retail Village, One of Canada’s Premier Four-Season Destinations

MONTREAL, Dec. 17, 2025 /PRNewswire/ – Brasswater, a leading private real estate investment and development firm, announced today that it…
Read More »
Press Release

Cision PR Newswire1 week ago
0

OnePay and Greenshades Partner to Bring Financial Wellness to Millions of Frontline Workers

Greenshades to embed direct access to OnePay’s financial wellness tools in its platform NEW YORK, Dec. 17, 2025 /PRNewswire/ —…
Read More »
Press Release

Cision PR Newswire1 week ago
0

Equifax Secures 27 New Patents in the Second Half of 2025

20 Patents Support the Organization’s Approach to Responsible AI, Designed to Accelerate Product Innovation that Help to Create New Financial…
Read More »
Cision PR Newswire1 week ago
0

Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development

DOVER, Del., Dec. 17, 2025 /PRNewswire/ — Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 is…
Read More »
Press Release

Cision PR Newswire1 week ago
0

Jazz Pharmaceuticals to Participate in Upcoming Investor Events

DUBLIN, Dec. 17, 2025 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the…
Read More »
Business Wire1 week ago

Jones Day Names 33 New Partners

WASHINGTON–(BUSINESS WIRE)–The global law firm Jones Day has announced that the following 33 lawyers listed below will be admitted to…
Read More »

Previous page Next page